Clinical Trials Directory

Trials / Completed

CompletedNCT04449900

Quantitative Evaluation of Parafoveal Microvasculature Changes in Eyes With Exudative Circumscribed Choroidal Haemangioma: An Optical Coherence Tomography Angiography Study

Status
Completed
Phase
Study type
Observational
Enrollment
82 (actual)
Sponsor
Sun Yat-sen University · Academic / Other
Sex
All
Age
10 Years – 80 Years
Healthy volunteers
Accepted

Summary

The study aims to quantitative evaluation of parafoveal microvasculature changes in eyes with exudative circumscribed choroidal haemangioma using optical coherence tomography angiography.

Detailed description

Circumscribed choroidal haemangioma (CCH) is an uncommon, potentially congenital benign vascular hamartomas which typically manifests as an elevated mass with reddish-orange pigmentation located posteriorly to the equator, mostly in the macular and peripapillary region. Despite its benign nature, cystoid macular edema (CME) or SRF due to the exudations from the exudative CCH can cause visual impairment. Diagnosis is often suspected clinically, and multimodal imaging is useful for the differential diagnosis of CCH from other malignant tumors such as melanoma. Optical coherence tomography angiography (OCTA) is a rapid, non-invasive, new imaging technology which could provide the capillary density (CD) of superficial and deep capillary plexus as well as the CD of choriocapillaris of the superficial, the latter two of which could not be seen on conventional FA or ICGA. However, little knowledge is known about the parafoveal microvasculature changes in eyes with exudative CCH on OCTA. Therefore, it is necessary to quantitative evaluation of parafoveal microvasculature changes in eyes with exudative CCH compared with healthy eyes without any disease. To the best of our knowledge, this is the first cross-sectional, case-control study to use OCTA to quantitative evaluation of parafoveal microvasculature changes in Eyes with exudative CCH compared with age- and gender-controlled healthy eyes.

Conditions

Interventions

TypeNameDescription
OTHERThis is observational study with the examination of OCTAThis is observational study with the examination of OCTA

Timeline

Start date
2017-03-01
Primary completion
2020-05-30
Completion
2020-05-30
First posted
2020-06-29
Last updated
2020-06-29

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04449900. Inclusion in this directory is not an endorsement.